Indeed, MMSET overexpression made cells more resistant to IR (Fig. 5d), in line with recent work showing that MMSET-high (t4;14)+ myeloma cells proliferate better upon treatment with DNA-damaging drugs than cells expressing wild-type MMSET levels [30]. The gene discussed is NSD2; the disease is plasma cell myeloma.